1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma

• Michael Bailey,
• Andrew White,
• Francesca Sparano,
• Alessandra Cesano,
• Corrado Caracò,
• Ester Simeone,
• Lucia Festino,
• Alfredo Budillon,
• Sarah Warren,
• Domenico Mallardo,
• Sarah Church,
• Vito Vanella,
• Ernesta Cavalcanti,
• Paolo Ascierto,
• Claudia Trojaniello,
• Maria Grazia Vitale,
• Margaret Ottaviano,
• Paolo Chiodini,
• Marilena Tuffanelli,
• Mario Fordellone,
• Bianca Arianna Facchini

Affiliations

Michael Bailey

3 Department of Epidemiology and Preventive Medicine (DEPM), Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia

Andrew White

6 Discipline of Ophthalmology, The University of Sydney, Sydney, New South Wales, Australia

Francesca Sparano

Medical Oncology, Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy

Alessandra Cesano

ESSA Pharma Inc, South San Francisco, California, USA

Corrado Caracò

Aff1 grid.417893.00000 0001 0807 2568Istituto Nazionale TumoriFondazione G Pascale Naples Italy

Ester Simeone

Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy

Lucia Festino

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy

Alfredo Budillon

Aff1 grid.417893.00000000108072568IRCCS National Cancer Institute G. Pascale Napoli Italy

Sarah Warren

NanoString Technologies Inc, Seattle, Washington, USA

Domenico Mallardo

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy

Sarah Church

NanoString Technologies, Seattle, WA, USA

Vito Vanella

Aff1 0000 0001 0807 2568grid.417893.0Unit of Melanoma, Cancer Immunotherapy and Development TherapeuticsIstituto Nazionale Tumori IRCCS Fondazione “G. Pascale” Via Mariano Semmola 80131 Naples Italy

Ernesta Cavalcanti

Aff4 0000 0001 0807 2568grid.417893.0Department of Diagnostic Pathology and LaboratoryIstituto Nazionale Tumori- IRCCS –Fondazione G. Pascale Napoli Italy

Paolo Ascierto

6Istituto Nazionale Tumori IRCCS ‘Fondazione G. Pascale’, Naples, Italy

Claudia Trojaniello

Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy

Maria Grazia Vitale

Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy

Margaret Ottaviano

Oncology Unit, Ospedale del Mare, Napoli, Campania, Italy

Paolo Chiodini

Medical Statistics Unit, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy

Marilena Tuffanelli

1Istituto Nazionale Tumori IRCCS Pascale, Naples, Italy

Mario Fordellone

2Universitiy of Campania ‘Luigi Vanvitelli’, 81100 Naples, Italy., Naples, Italy

Bianca Arianna Facchini

1Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy